Female friends know that menstruation is very important to us. The symptoms during menstruation may be manifestations of some gynecological diseases. For example, the symptoms of dysmenorrhea are partly caused by endometriosis. Other gynecological diseases, such as polycystic ovary, uterine fibroids, etc., if not treated in time, affect fertility, and harm will endanger our lives.
In response to this situation, two scientists at Harvard decided to do something, so they made the ordinary tampon into a "wearable device" – smart sliver, they are Stephen Gire and Ridhi Tariyal.
Tariyal believes that once-a-year fixed medical examinations are too low for women, she believes that there should be a new blood testing system to help women, so they can actively monitor their health problems. In the process of thinking about how to get a sufficient and frequent blood sample, one day, she suddenly realized that she actually had a lot of blood every month, so she had a flash of light, and the sliver could be used as a blood collection. What about tools? Coupled with the right technology, is it possible to detect a series of biomarkers in the blood and then transfer this information to the database?
So in 2013, Tariyal and Gire started a business together! They founded a company called NextGen Jane to develop "smart tampon". They have conducted extensive surveys across the country, collecting information, understanding what medical conditions women have and what they are worried about, and hope to better serve their target customers.
In 2015, a sequencing company, Illumina, took a look at NextGen Jane's huge market potential and provided them with accelerator projects and funding. Using Illumina's technical resources, they detected how the RNA expression of a blood sample changes over time during the menstrual cycle.
NextGen Jane's current focus is on endometriosis and ovarian cancer, which are the world's biggest problems to be solved. A considerable number of women endure infertility due to insufficient attention to endometriosis. Similarly, because the symptoms are not obvious, many patients' ovarian cancer is often found in the late stage, which makes the patient's survival rate greatly reduced.
Puyang Linshi Medical Supplies Co., Ltd. , https://www.linshihealths.com